SANOFI-AVENTIS VIETNAM CO., LTD. is the Vietnamese subsidiary of Sanofi, one of the world’s leading pharmaceutical groups headquartered in France. In Vietnam, the company has built a long-standing presence through both manufacturing and distribution of prescription medicines, vaccines, and consumer healthcare products. With decades of local engagement, SANOFI-AVENTIS VIETNAM is a key pillar of Vietnam’s pharmaceutical infrastructure, particularly in the treatment of chronic diseases and public health initiatives.

Legally structured as a 100% foreign-invested limited liability company, SANOFI-AVENTIS VIETNAM is registered under business ID 0300831037. Its head office and manufacturing facilities are located in Ho Chi Minh City, with production operations adhering to global GMP and ISO quality standards. The company plays a strategic role in regional supply chains, exporting medicines to ASEAN countries while maintaining a strong domestic market footprint. SANOFI-AVENTIS VIETNAM is not publicly listed, but it reports transparently and complies with both Vietnamese and international regulatory frameworks.

In fiscal year 2023, SANOFI-AVENTIS VIETNAM reported USD 212.44 million in total revenue, placing it among the top-revenue-generating pharmaceutical entities in Vietnam. However, net profit stood at USD 4.94 million, reflecting tighter margins amid high operational costs and increasing competition. The company held total assets of USD 100.33 million and owner’s equity of USD 61.44 million, indicating a solid financial foundation and strong capitalization. These figures underscore Sanofi’s commitment to long-term investment and local production in the Vietnamese market.

As a key supplier to Vietnam’s healthcare system, SANOFI-AVENTIS VIETNAM offers critical therapeutic products for diabetes, cardiovascular disease, oncology, and pediatrics, as well as one of the country’s most reliable vaccine portfolios. Its partnerships with the Ministry of Health and ongoing efforts in clinical trials and public health campaigns further reinforce its status as a global-standard pharmaceutical provider operating locally. With a deep pipeline of innovation and a strong brand reputation, the company is expected to continue playing a central role in Vietnam’s healthcare development.

For financial institutions, procurement professionals, and international partners, Vanguard Business Information LLC (VBI) provides expert-level company profiles, credit evaluations, and operational insights into companies like SANOFI-AVENTIS VIETNAM. As Vietnam's healthcare landscape evolves, Sanofi’s continued presence underscores the value of trusted multinationals in national health progress.